58
Participants
Start Date
February 28, 2014
Primary Completion Date
May 31, 2017
Study Completion Date
October 31, 2017
D-Cycloserine
Participants will receive 10 administrations of 50 mg of D-Cycloserine by mouth one hour before CBT sessions, weekly, in weeks 3-12.
Placebo
Participants will receive 12 weekly administrations of placebo by mouth 1 hour before CBT sessions, from weeks 1-12.
Cognitive Behavioral Therapy
Participants will engage in a Cognitive Behavioral Therapy treatment plan designed for psychotic delusions. The program will consist of 12 one hour sessions, once weekly from study week 1-week 12.
New York Langone Medical Center/Bellevue Hospital, New York
Sheppard Pratt, Baltimore
National Institute of Mental Health (NIMH)
NIH
NYU Langone Health
OTHER